Core Scientific, Inc.
CORZQ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $3 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $0 | $1 | $0 |
| Enterprise Value | $1 | $0 | $4 | $3 |
| Revenue | $1 | $1 | $1 | $0 |
| % Growth | -21.5% | 17.6% | 802.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 24.6% | 1.3% | 43.9% | 15.6% |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 22.8% | -32.9% | 33.8% | 19.8% |
| Net Income | -$0 | -$2 | $0 | -$0 |
| % Margin | -49.1% | -335.2% | 8.7% | -20.2% |
| EPS Diluted | -0.644 | -6.3 | 0.15 | -0.039 |
| % Growth | 89.8% | -4,300% | 489.6% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$1 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |